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Résumé en
anglais
Local ischemic postconditioning (IPost) and remote ischemic perconditioning (RIPer)
are promising methods to decrease ischemia–reperfusion (I/R) injury. We tested
whether the use of the two procedures in combination led to an improvement in
cardioprotection through a higher activation of survival signaling pathways. Rats
exposed to myocardial I/R were allocated to one of the following four groups:
Control, no intervention at myocardial reperfusion; IPost, three cycles of 10-s
coronary artery occlusion followed by 10-s reperfusion applied at the onset of
myocardial reperfusion; RIPer, 10-min limb ischemia followed by 10-min reperfusion
initiated 20 min after coronary artery occlusion; IPost+RIPer, IPost and RIPer in
combination. Infarct size was significantly reduced in both IPost and RIPer (34.25 ±
3.36 and 24.69 ± 6.02%, respectively) groups compared to Control (54.93 ± 6.46%,
both p < 0.05). IPost+RIPer (infarct size = 18.04 ± 4.86%) was significantly more
cardioprotective than IPost alone (p < 0.05). RISK pathway (Akt, ERK1/2, and
GSK-3β) activation was enhanced in IPost, RIPer, and IPost+RIPer groups compared
to Control. IPost+RIPer did not enhance RISK pathway activation as compared to
IPost alone, but instead increased phospho-STAT-3 levels, highlighting the crucial
role of the SAFE pathway. In IPost+RIPer, a SAFE inhibitor (AG490) abolished
cardioprotection and blocked both Akt and GSK-3β phosphorylations, whereas RISK
inhibitors (wortmannin or U0126) abolished cardioprotection and blocked STAT-3
phosphorylation. In our experimental model, the combination of IPost and RIPer
improved cardioprotection through the recruitment of the SAFE pathway. Our
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